Pliant Therapeutics
PLRX
PLRX
88 hedge funds and large institutions have $241M invested in Pliant Therapeutics in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
4.23% less ownership
Funds ownership: 87.55% → 83.32% (-4.2%)
4% less funds holding
Funds holding: 92 → 88 (-4)
Holders
88
Holding in Top 10
3
Calls
$2.93M
Puts
$1.45M
Top Buyers
| 1 | +$3.77M | |
| 2 | +$3.6M | |
| 3 | +$2.87M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.86M |
| 5 |
Goldman Sachs
New York
|
+$2.31M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$6.5M | |
| 3 | -$2.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.29M |
| 5 |
Walleye Capital
New York
|
-$1.67M |